Clinical Medicine Journal
Articles Information
Clinical Medicine Journal, Vol.1, No.2, Jun. 2015, Pub. Date: May 11, 2015
A Newborn with Methylmalonic Acidemia Accompanied by Extremely High Ammonia Levels
Pages: 48-51 Views: 1455 Downloads: 1064
Authors
[01] Sultan Kaba, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
[02] Nihat Demir, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
[03] Keziban Bulan, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
[04] Murat Dogan, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
[05] Kaan Demiroren, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
[06] Nesrin Ceylan, Department of Paediatrics, School of Medicine, Yuzuncu Yil University, Van, Turkey.
Abstract
Most organic acidemias become clinically apparent during neonatal period or early infancy. Infants typically have severe metabolic acidosis with increased anion gap, ketosis and hyperammonemia. Extremely high ammonia levels exceeding 1000 µmol/L is a discriminative feature for urea cycle defect while levels exceeding 200-300 µmol/L are rarely encountered in other reasons of hyperammonemia. Lethargy developed in a boy with extremely high ammonia levels (3693 µmol/L) on the post-natal day 3. Higher extremes in ammonia are mainly observed in urea cycle defects. We presented this case which was diagnosed as methylmalonic acidemia by specific tests to emphasize that extremely high ammonia levels can be seen in organic acidemias.
Keywords
Organic Acidemia, Hyperammonemia, Methylmalonic Academia, Urea Cycle Defects
References
[01] H.F. Willard, L.E. Rosenberg, Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts: evidence for allelic heterogeneity, genetic compounds, and codominant expression, J. Clin. Invest. 89 (1980) 690–698.
[02] Hörster F., Hoffmann G.F. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria-recent advances and new challenges. Pediatr Nephrol. 2004; 19:1071–4.
[03] Karam PE, Habbal MZ, Mikati MA, Zaatari GE, Cortas NK, Daher RT. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: A twelve-year experience. Clin Biochem. 2013;46:1787–92.
[04] Srinivas KV, Want MA, Freigoun OS, Balakrishna N. Methylmalonic acidemia with renal involvement: A case report and review of literature. Saudi J Kidney Dis Transpl. 2001; 12:49–53.
[05] Song YZ, Li BX, Hao H, Xin RL, Zhang T, Zhang CH, et al. Selective screening for inborn errors of metabolism and secondary methylmalonic aciduria in pregnancy at high risk district of neural tube defects: A human metabolome study by GC-MS in China.Clin Biochem. 2008; 41:616–20.
[06] Vaidyanathan K, Narayanan MP, Vasudevan DM. Organic acidurias: An updated review. Indian J Clin Biochem. 2011; 26:319–25.
[07] Fenichel GM. Clinical pediatric neurology: A signs and symptoms approach: Elsevier Health Sciences, 2009.
[08] Swaiman K. Aminoacidopathies and organic acidemias resulting from deficiency of enzyme activity. In: Swaiman KF, editor. Pediatric Neurology-Principles and Practice. 2nd Ed. Missouri: Mosby; 1994. pp. 1195–232.
[09] Dionisi-Vici C, Deodato F, Röschinger W, Rhead W, Wilcken B. ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006; 29:383–9.
[10] Swaiman KF. Aminoacidopathies and organic acidemias resulting from deficiency of enzyme activity and transport abnormalities. Swaiman KF, Ashwal S. Pediatric Neurology Practice and Principles. 3th ed. St Louis Baltimore-Toronto: Mosby Company 1999: 395.
[11] Matsui SM, Mahoney MJ, Rosenberg LE. The natural history of the inherited methylmalonic acidemias. N Engl J Med 1983; 308:857-61. http://dx.doi.org/10.1056/NEJM198304143081501 PMid: 6132336.
[12] Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propi¬onate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001; 2165-93.
[13] Miousse IR, Watkins D, Coelho D, et al. Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism. J Pediatr 2009; 154:551.
[14] Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 2006; 142C (2):104-12. http://dx.doi.org/10.1002/ajmg.c.30090 PMid: 16602092.
[15] Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child 1998; 78:508-12. http://dx.doi.org/10.1136/adc.78.6.508 PMid: 9713004 PMCid: 1717592).
[16] Nyhan WL, Ozand PT. Atlas of Metabolic Diseases, 1st ed, Chapman and Hall Medical, London 1998.
[17] Leonard JV, Morris AA. Inborn errors of metabolism around time of birth. Lancet 2000; 356:583.
[18] Rajpoot DK, Gargus JJ. Acute hemodialysis for hyperammonemia in small neonates. Pediatr Nephrol 2004; 19:390.
[19] Di Donato S, Rimoldi M, Garavaglia B, Uziel G. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clin Chim Acta 1984; 139:13.
[20] Guven A, Cebeci N, Dursun A, Aktekin E, Baumgartner M, Fowler B. Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant. Pediatr Diabetes. 2012; 13:e22–5.
[21] Levrat V, Forest I, Fouilhoux A, et al. Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia? Orphanet J Rare Dis. 2008; 3:2.
[22] Wappner RS. Disorders of amino acid and organic acid metabolism. In: Oski's pediatrics: Principles and practice, 4th ed, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott, Williams & Wilkins, Philadelphia 2006. p.2153.
[23] Brismar J, Ozand PT. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. AJNR Am J Neuroradiol 1994; 15:1459.
[24] Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr 1999; 134:268.
600 ATLANTIC AVE, BOSTON,
MA 02210, USA
+001-6179630233
AIS is an academia-oriented and non-commercial institute aiming at providing users with a way to quickly and easily get the academic and scientific information.
Copyright © 2014 - 2017 American Institute of Science except certain content provided by third parties.